Cirugía y Cirujanos

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Cirugía y Cirujanos >Year 2013, Issue 4

Hernández-Solís A, Garcia-Hernández C, Reding-Bernal A, Cruz-Ortiz H, Cicero-Sabido R
Malignant mesothelioma risk factors, experience in the General Hospital of Mexico
Cir Cir 2013; 81 (4)

Language: Español
References: 25
Page: 312-316
PDF: 376.73 Kb.

[Full text - PDF]


Background: Malignant mesothelioma is a neoplasm of bad prognosis, it is linked with asbestos contact, but there are cases without this antecedent.
Objective: To investigate the relationship of asbestos exposition and other factors with malignant mesothelioma.
Methods: Retrospective analysis of histologic confirmed cases of malignant mesothelioma, neoplasic familiar history, tobacco smoking, exposition to wood smoke and to asbestos, were annotated in a paired case/control study 1: 1-3 with logistic regression model to identify risk factors for OR.
Results: 61 cases of malignant mesothelioma were confirmed by histopathologic study, 41 male and 20 female. Mean age was 56 years ± 13 years; 56 cases (91.8%) correspond to epithelial malignant mesothelioma, three sarcomatous (4.9%) one desmoplastic and one biphasic. One in eight (13.1%) had exposure to asbestos. Model of logistic regression with four variables: history of familiar cancer, tobacco smoking, wood smoke and asbesto exposition, the last one with an OR= 3.083 and p› 0.05. No other variables found to be a risk factor for malignant mesothelioma.
Conclusions: Exposure to asbestos is a risk factor for malignant mesothelioma, which is confirmed in this study, however it is important to extend the investigation of other possible causal factors of this disease.

Key words: Malignant mesothelioma, asbesto, wood smoke exposition.


  1. Berry G, Newhouse ML, Antonis P. Combined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workers. Brit J Ind Med 1985;42:12-18.

  2. Pacurari M, Castranova V, Vallyathan V. Single- and Multi-Wall Carbon Nanotubes Versus Asbestos: Are the Carbon Nanotubes a New Health Risk to Humans? J Toxicol Environ Health A 2010;73:378-395.

  3. Jaurand MCF, Renier A, Daubriac J. Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk? Part Fibre Toxicol 2009;6:16.

  4. Yarborough CM. The risk of mesothelioma from exposure to chrysotile asbestos. Curr Opin Pulm Med 2007;13:334-338.

  5. You B, Blandin S, Gérinière L, Lasset C, Souquet PJ. Family mesotheliomas: genetic interaction with environmental carcinogenic exposure? Bull Cancer 2007;94:705-710.

  6. Dikensoy O. Mesothelioma due to environmental exposure to erionite in Turkey. Curr Opin Pulm Med 2008;14:322-325.

  7. Hirvonen A, Mattson K, Karjalainen A, Ollikainen T, Tammilehto L, Hovi T, et al. Simian virus 40 (SV40)-like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40- contaminated polio vaccines. Mol Carcinog 1999;26:93-99.

  8. Ugolini D, Neri M, Ceppi M, Cesario A, Dianzani I, Filiberti R. Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. Mutat Res 2008;658:162- 171.

  9. Hirvonen A, Tuimala J, Ollikainen T, Linnainmaa K, Kinnula V. Manganese superoxide dismutase genotypes and asbestos-associated pulmonary disorders. Cancer Lett 2002;178:71-74.

  10. Carbone M, Bedrossian CWM. The pathogenesis of mesothelioma. Semin Diagn Pathol 2006;23:56-60.

  11. Bacci B, Morandi F, De Meo M, Marcato PS. Ten cases of feline mesothelioma: an immunohistochemical and ultrastructural study. J Comp Pathol 2006;134:347-354.

  12. García-López MP, Barrera-Rodríguez R. Mesotelioma maligno: descripción clínica de 45 casos con y sin exposición a asbestos. Salud Pública Méx 2000;42:511-519.

  13. Carbone M, Kratzke RA, Testa JR. The patogenesis of mesothelioma. Semin Oncol 2002;29:2-17.

  14. Robinson BWS, Musk AW, Lake RA. Malignant mesothelioma. Lancet 2005;366(9483):397-408.

  15. van Meerbeeck JP, Hillerdal G. Screening for Mesothelioma. More Harm than Good? Am J Respir Crit Care Med 2008:178:781-782.

  16. Delgado J, Martinez LM, Sanchez TT, Ramirez A, Iturria C, Gonzalez-Avila G. Lung Cancer Pathogenesis Associated With Wood Smoke Exposure. Chest 2005;128:124-131.

  17. Muscat JE, Wynder EL. Cigarette Smoking, Asbestos Exposure, and Malignant Mesothelioma. Cancer Res 1991;51:2263-2267.

  18. Robinson BWS, Lake RA. Advances in Malignant Mesothelioma. N Engl J Med 2005;353:1591-1603.

  19. Villena Garrido V, López Encuentra A, Echave-Sustaeta J, Álvarez Martínez C, Rey Terrón L, Sotelo MT, et al. Pleural Mesothelioma: Experience With 62 Cases in 9 Years. Arch Bronconeumol 2004;40:203-208.

  20. West SD, Lee YC. Management of malignant pleural mesothelioma. Clin Chest Med 2006;27:335-354.

  21. McDonald JC, Edwards CW, Gibbs AR, Lloyd HM, Pooley FD, Ross DJ, et al. Case-Referent Survey of Young Adults with Mesothelioma: II. Occupational Analysis. Ann Occup Hyg 2001;45:519-523.

  22. Gaafar RM, Eldin NHA. Epidemc of mesothelioma in Egypt. Lung Cancer 2005;49(suppl 1):S17-S20.

  23. Filiberti R, Montanaro F. Epidemiology of pleural mesothelioma in Italy. Lung Cancer 2004;45(suppl 1):S25-S27.

  24. Kazan-Allen L. Asbestos and mesothelioma. Worldwide trends. Lung Cancer 2005;49(suppl 1):S3-S8.

  25. Villalba Caloca J, Martínez Heredero R. Frecuencia del mesotelioma maligno. Revisión clínica. Experiencia en el Instituto Nacional de Enfermedades Respiratorias durante 1998-2002. Rev Inst Nal Enf Resp Mex 2003;16:150-157.

>Journals >Cirugía y Cirujanos >Year 2013, Issue 4

· Journal Index 
· Links 
Copyright 2010